Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT00571766
  4. Details
NCT00571766 Clinical Trial

Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy

Hypertension in Pregnancy Clinical Trial

Official title:
Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00571766
Other study ID # Oral L-Arginine
Secondary ID
Status Completed
Phase Phase 3
First received December 11, 2007
Last updated September 9, 2009
Start date November 2007
Est. completion date December 2008

Study information
Verified date September 2009
Source University of Modena and Reggio Emilia
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of oral L-Arginine in pregnant women with chronic hypertension.

Recruitment information / eligibility
Status Completed
Enrollment 80
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Pregnant women between 18-20 week of gestation with chronic hypertension

Exclusion Criteria:

- Maternal or fetal disease

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• L-Arginine
Oral L-Arginine 2g, twice a day for 14 weeks
• Placebo
Placebo 2 g twice a day for 14 weeks

Locations
Country Name City State
Italy University of Modena and Reggio Emilia Modena Emilia Romagna

Sponsors (1)
Lead Sponsor Collaborator
University of Modena and Reggio Emilia

Country where clinical trial is conducted

Italy, 

Outcome
Type Measure Description Time frame Safety issue
Primary to evaluate blood pressure changes in pregnant women with chronic hypertension during oral arginine or placebo treatment in second trimester of gestation. 14 weeks Yes
Secondary To evaluate if is necessary add a conventional therapy for hypertension, to evaluate the maternal and fetal outcomes and possible complications, to evaluate the safety of L-Arginine. 14 weeks Yes
See also
  Status Clinical Trial Phase
Completed NCT00974714 - L-arginine Effects on Chronic Hypertension in Pregnancy Phase 3
Terminated NCT03595982 - Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? Phase 4
Completed NCT04486170 - Assessment of Postpartum Education to Improve Compliance N/A
Completed NCT03506724 - Response to Anti-hypertensives in Pregnant and Postpartum Patients Phase 4
Completed NCT03613714 - Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy N/A
Recruiting NCT04604535 - The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy N/A
Completed NCT00412230 - Insulin Resistance and Hypertensive Disorders in Pregnancy N/A
Active, not recruiting NCT05049616 - Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension Phase 4
Completed NCT04119232 - Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy N/A
Completed NCT04633551 - Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes N/A
Completed NCT05859282 - Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension
Active, not recruiting NCT05543265 - Bridging the Gap From Postpartum to Primary Care N/A
Recruiting NCT05473767 - Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children N/A
Recruiting NCT05683093 - Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Completed NCT06403722 - Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
Recruiting NCT05852054 - Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP) Phase 3
Recruiting NCT05137808 - Understanding Blood Pressure Changes After Birth
Completed NCT03961360 - Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida Phase 2/Phase 3
Active, not recruiting NCT03648645 - Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure N/A
Recruiting NCT06054841 - Reshaping Postpartum Follow-up N/A